publication date: Sep. 11, 2015

Chad Mirkin Awarded Sackler Prize from National Academy of Sciences 


CHAD MIRKIN was named the inaugural recipient of the Raymond and Beverly Sackler Prize in Convergence Research by the National Academy of Sciences.

Mirkin is a professor at Northwestern University and director of its International Institute for Nanotechnology.

He was awarded the $400,000 prize “for impressively integrating chemistry, materials science, molecular biology, and biomedicine in the development of spherical nucleic acids that are widely used in the rapid and automated diagnosis of infectious diseases and many other human diseases—including cancers and cardiac disease—and in the detection of drug-resistant bacteria.” Mirkin will receive two-thirds of the prize money; the remaining third will support his research at Northwestern.

The prize will be presented Oct. 13 at the National Academy of Sciences building in Washington, D.C.

The annual prize was established through a gift from Raymond and Beverly Sackler and their foundation to recognize significant advances in convergence research, the integration of two or more of the following disciplines: mathematics, physics, chemistry, biomedicine, biology, astronomy, earth sciences, engineering, and computational science.

“By successfully combining the power of many scientific disciplines, Chad Mirkin created an entirely new kind of nucleic acid that is fueling critical advances in the diagnosis and treatment of devastating illnesses,” said National Academy of Sciences President Ralph Cicerone. “We are pleased to recognize his significant achievements in convergence research with this prize.”

Mirkin is the George B. Rathmann Professor of Chemistry and professor of medicine, chemical and biological engineering, biomedical engineering, … Continue reading 41-33 Chad Mirkin Awarded Sackler Prize from National Academy of Sciences

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.